ELCELYX THERAPEUTICS INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	China	12
#2	United States	12
#3	WIPO (World Intellectual Property Organization)	12
#4	Singapore	11
#5	EPO (European Patent Office)	10
#6	Canada	9
#7	Brazil	8
#8	South Africa	8
#9	Israel	7
#10	Republic of Korea	7
#11	Argentina	6
#12	Australia	6
#13	Mexico	6
#14	Chile	5
#15	Japan	5
#16	Hong Kong	4
#17	EAPO (Eurasian Patent Organization)	1
#18	New Zealand	1
#19	Philippines	1

#	Technology
#1	Medical preparations
#2	Therapeutic chemical compounds
#3	Heterocyclic compounds
#4	Acyclic or carbocyclic compounds
#5	Special acyclic compounds
#6	Sugars
#7	Peptides

Publication	Filing date	Title
US2019307708A1	2019-02-11	Compositions and methods for treating metabolic disorders
MX2015008625A	2014-01-03	Delayed-release composition comprising biguanide.
US2015196509A1	2013-07-11	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN104780915A	2013-07-11	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
WO2013158928A2	2013-04-18	Chemosensory receptor ligand-based therapies
US2013177604A1	2013-01-05	Compositions and methods of treating metabolic disorders
NZ626578A	2013-01-05	Compositions and methods for treating metabolic disorders
KR20190120430A	2012-07-11	Biguanide compositions and methods of treating metabolic disorders
CA2823397A1	2012-01-06	Chemosensory receptor ligand-based therapies
BR112013009635A2	2011-10-18	chemosensory receptor ligand-based therapies
EP2629773A2	2011-10-18	Chemosensory receptor ligand-based therapies
AU2011317143A1	2011-10-18	Chemosensory receptor ligand-based therapies
EP2629609A2	2011-10-18	Chemosensory receptor ligand-based therapies
EP2629774A2	2011-10-18	Chemosensory receptor ligand-based therapies
CA2800470A1	2010-10-19	Chemosensory receptor ligand-based therapies
AU2010239311A1	2010-04-20	Chemosensory receptor ligand-based therapies